Journal · Inflammation biology · Updated 21 November 2026
Inflammation
Read Inflammation articles on DeepDyve. No university library needed.
Inflammation covers how inflammation starts, spreads and might be treated, from neutrophil extracellular traps and inflammasomes in brain injury to gut-bone signaling in spondyloarthritis and inflammatory retinal disease. Springer Nature publishes it, and it has published since 1975. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
Inflammation at a glance
- Full title
- Inflammation
- Abbreviation (NLM)
- Inflammation
- Publisher
- Springer Nature
- Print ISSN
- 0360-3997
- Online ISSN (eISSN)
- 1573-2576
- First published
- 1975
- Subjects
- Allergy and Immunology, Pathology
- Access model
- Open access since 2025
Ways to access Inflammation
All of the articles Inflammation published from January 1 to November 20, 2026 are open access and free to read. For older articles, look for the authors’ manuscript, check a library, or read them on DeepDyve.
- Open access articles. 100% of Inflammation articles published from January 1 to November 20, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
- The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
- Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to Inflammation. Check its journal list and whether it offers remote access.
- DeepDyve. Read Inflammation articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.
Impact factor and metrics
Inflammation’s 2025 Journal Impact Factor is 5.4, and its 5-year Impact Factor is 5.9.
5.4
Journal Impact Factor (2025)
5.9
5-year Impact Factor (2025)
3 days
Median time to first decision
1.3M
Downloads (2025)
Source: journal metrics on the Inflammation homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.
Recent Inflammation research worth reading
Published January to April 2026. Summaries describe what the authors report.
-
Mitochondria as Inducers of Neutrophil Extracellular Traps
The authors review how mitochondrial damage signals such as mitochondrial DNA, ATP and cardiolipin trigger neutrophil extracellular traps through receptors usually reserved for detecting pathogens, and discuss their role in trauma and wound healing and the challenges facing therapies.
Bečka et al. · Inflammation, published online January 26, 2026 · DOI 10.1007/s10753-025-02432-z
-
HSP60 Mediates NLRP3 Inflammasome-Dependent Microglial Pyroptosis Via the TLR4/MyD88/NF-κB Signaling Axis After Subarachnoid Hemorrhage
In mice and microglia modeling subarachnoid hemorrhage, the authors report that HSP60 rose after the bleed and drove microglial pyroptosis through the TLR4/MyD88/NF-κB pathway and NLRP3 inflammasome, and that inhibiting it with Mizoribine reduced early brain injury.
Hu et al. · Inflammation, published online January 12, 2026 · DOI 10.1007/s10753-025-02442-x
-
TSG-6 Activated MSC-derived Extracellular Vesicles Present Altered micro-RNA Contents and Ameliorate the Inflammatory Phenotype of Macrophages in Vitro
Using CRISPR to activate the TSG-6 gene in mesenchymal stem cells, the authors report 15 differentially expressed miRNAs in the cells’ extracellular vesicles, which markedly reduced pro-inflammatory cytokines in LPS-stimulated macrophages.
Martinez-Zalbidea et al. · Inflammation, published online January 13, 2026 · DOI 10.1007/s10753-025-02398-y
-
Intestinal Sclerostin Deficiency Links Gut Dysbiosis to Altered Serotonin Homeostasis in Axial Spondyloarthritis
Studying ileal biopsies from 25 patients with axial spondyloarthritis and 20 healthy controls, along with rat and mouse models, the authors identify a gut microbiota-dependent sclerostin-serotonin axis that regulates serotonin production and may contribute to gut-bone pathology in the disease.
Mauro et al. · Inflammation, published online January 10, 2026 · DOI 10.1007/s10753-025-02393-3
-
Effects of New P2X7R Antagonists on Retinal Inflammatory Degenerative Conditions
Screening about 10,000 FDA approved drugs for P2X7 receptor antagonists, the authors report that tipranavir and teniposide were well tolerated by retinal cells and protected them in models of glaucoma, diabetic retinopathy and age-related macular degeneration.
Platania et al. · Inflammation, published online April 25, 2026 · DOI 10.1007/s10753-026-02513-7
Related journals
Questions about Inflammation
How can I read Inflammation articles without a subscription?
100% of Inflammation articles published from January 1 to November 20, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Inflammation articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for Inflammation?
Inflammation isn’t abbreviated: its NLM (PubMed) abbreviation is simply Inflammation.
What is the ISSN of Inflammation?
The print ISSN is 0360-3997 and the online ISSN is 1573-2576.
What is the impact factor of Inflammation?
Inflammation’s Journal Impact Factor is 5.4 (2025), and its 5-year Impact Factor is 5.9, according to Springer Nature’s published metrics.
Is Inflammation open access?
Yes. Inflammation has published open access since 2025: 250 of the 250 articles it published from January 1 to November 20, 2026 carry a Creative Commons license, per Crossref.
Inflammation articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.
Start reading Inflammation today
One month free, then less than $2 a day. Inflammation, plus millions of articles from thousands of journals.





